Our results demonstrated that CCDC50 not only showed significantly positive correlations with ABC subtype, tumor stage and number of extranodal sites, but also suggested poor outcomes in DLBCL patients. The gene discussed is CCDC50; the disease is diffuse large B-cell lymphoma.